
While nursing home residents are at high risk for bad outcomes if they get COVID-19, use of antiviral treatments, such as monoclonal antibodies, was low through most of 2021 and 2022. The authors of a new study, led by Brian McGarry, a health services researcher at the University of Rochester Medical Center in New York,… read on > read on >